NSE: CHEMBONDCH · BSE: 544450
CHEMBOND CHEMICAL LIMITED
Manufactures and sells specialty chemicals across four business segments, with Water Technologies dominant at 87% of FY26 revenue of Rs.326.15 crore. Water Technologies supplies water treatment chemicals to industrial and public-sector customers such as Indian Oil, NTPC and NPC, with H2 FY26 revenue of Rs.162 crore, volume of 14,813 metric tons, and a single-month peak of Rs.32 crore in March 2026. Construction Chemicals sells specialty products to dealers and distributors in Maharashtra and Gujarat, growing 15% in FY26 on a smaller base. The Cleaning & Hygiene segment operates as a JV with Germany's Calvatis and grew 22% in FY26. Distribution, the smallest segment, grew 40% on new product additions. The company runs 3 manufacturing locations with a 950-person team, has zero debt, and holds Rs.65 crore in net cash. Raw materials — chiefly metals including zinc and molybdenum — are the biggest cost line at 41.2% of revenue, and a post-February 2026 surge in these inputs is currently pressuring EBITDA margins by roughly 3%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Water Technologies (87%), Construction Chemicals, Cleaning & Hygiene, Distribution. Specialty chemicals, water-treatment dominant, B2B industrial
Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 292 | 326 |
| EBITDA (ex other income) | 42 | 47 |
| margin % | 14.3 | 14.5 |
| Owners' profit | 31 | 35 |
| EPS, as reported (₹) | 11.54 | 12.93 |
| ROE % · ROCE % | 17.7 · 24.1 | 16.8 · 21.7 |
| Debt / equity (x) | 0.00 | 0.00 |
| Cash from operations | 10 | 8 |
| Capex | (5) | (7) |
Exhibit 2: Quarterly performance, last 6 quarters
| ₹ crore | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|
| Revenue | 78 | 65 | 73 | 86 | 101 | 86 |
| Profit before tax | 12 | 10 | 10 | 12 | 14 | 13 |
| Net profit | 9 | 6 | 7 | 10 | 12 | 10 |
| EPS (₹) | 3.27 | 2.33 | 2.69 | 3.62 | 4.31 | 3.54 |
Exhibit 3: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Oct 2026 · Quarterly certificate confirms no physical share certificates held | compliance | minimal | — | — |
| 28 Sept 2026 · Trading window closed from Oct 1, 2026 till Q2 results announcement | compliance | minimal | — | — |
| 26 Aug 2026 · Promoter Nirmal Shah buys 15,000 shares of Chembond Chemicals | ownership changes | medium | — | — |
| 10 Aug 2026 · Promoters buy 30,500 shares of Chembond Chemicals via open market | ownership changes | high | — | — |
| 31 Jul 2026 · AGM 2026 results: all 3 resolutions passed, final dividend approved | board shareholder meetings | low | — | — |
| 31 Jul 2026 · 3rd AGM held; final dividend of Rs.1.25 per share declared | board shareholder meetings | low | — | — |
| 31 Jul 2026 · 3rd AGM held on July 31, 2026 via video conferencing | board shareholder meetings | medium | — | — |
| 17 Jul 2026 · Newspaper publication of Q1 FY27 results filed with BSE and NSE | compliance | minimal | — | — |
| 16 Jul 2026 · Chembond Chemicals Q1 FY27 Results: Revenue Up 32% YoY, PAT Jumps 52% | results | high | — | — |
| 8 Jul 2026 · Certificate confirms all shares held in demat form for Q1 FY27 | compliance | minimal | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.